Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27980006.
- Also identified by DOI 10.2337/db16-0806 and PMC identifier 5384660.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The American Diabetes Association, JDRF, the European Association for the Study of Diabetes, and the American Association of Clinical Endocrinologists convened a research symposium, "The Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis" on 10-12 October 2015. International experts in genetics, immunology, metabolism, endocrinology, and systems biology discussed genetic and environmental determinants of type 1 and type 2 diabetes risk and progression, as well as complications. The participants debated how to determine appropriate therapeutic approaches based on disease pathophysiology and stage and defined remaining research gaps hindering a personalized medical approach for diabetes to drive the field to address these gaps. The authors recommend a structure for data stratification to define the phenotypes and genotypes of subtypes of diabetes that will facilitate individualized treatment.
Medical subject headings
- Diabetes Complications
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2